OLMA (Olema Pharmaceuticals) OCF Margin %: 0.00% (As of Mar. 2026)


OLMA Olema Pharmaceuticals inc OLMA
33 GF Score
Price $11.21
! 2 Warning Signs
View Full Analysis

What is Olema Pharmaceuticals OCF Margin %?

Olema Pharmaceuticals OLMA +0.63% 33 OCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates OLMA with a GF Score™ of 33/100. The stock has 2 warning signs investors should review. Among 960 Biotechnology companies, Olema Pharmaceuticals ranks worse than 104166.56% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Olema Pharmaceuticals's Cash Flow from Operations for the three months ended in Mar. 2026 was $-45.99 Mil. Olema Pharmaceuticals's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, Olema Pharmaceuticals's OCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Olema Pharmaceuticals's current OCF Yield % is -15.19%.

The historical rank and industry rank for Olema Pharmaceuticals's OCF Margin % or its related term are showing as below:


OLMA's OCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -68.59
* Ranked among companies with meaningful OCF Margin % only.

Olema Pharmaceuticals OCF Margin % Related Terms

Olema Pharmaceuticals OCF Margin % Historical Data

* Premium members only.

The historical data trend for Olema Pharmaceuticals's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Olema Pharmaceuticals OCF Margin % Chart

Olema Pharmaceuticals Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Olema Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
OLMA
33GF Score
Olema Pharmaceuticals inc OLMA
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Olema Pharmaceuticals OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Olema Pharmaceuticals's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-146.716/0
= %

Olema Pharmaceuticals's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-45.987/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Olema Pharmaceuticals (OLMA) has a OCF Margin % of 0.00% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Olema Pharmaceuticals and its competitors. According to the industry distribution chart, Olema Pharmaceuticals ranks #999999 out of 960 companies in the Biotechnology industry.
Is Olema Pharmaceuticals' OCF Margin % too high?
Olema Pharmaceuticals' current OCF Margin % is 0.00%. Based on the distribution chart, Olema Pharmaceuticals ranks #999999 out of 960 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Olema Pharmaceuticals has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Olema Pharmaceuticals' OCF Margin % compare to AKTS and ZBIO?
According to the Biotechnology industry distribution chart, Olema Pharmaceuticals ranks #999999 out of 960 companies for OCF Margin %. This places Olema Pharmaceuticals in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Olema Pharmaceuticals and its competitors. Olema Pharmaceuticals's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Olema Pharmaceuticals stock overvalued right now?
Olema Pharmaceuticals (OLMA) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Olema Pharmaceuticals' overall GF Score™ is 33/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Olema Pharmaceuticals (OLMA), the current OCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Olema Pharmaceuticals Business Description

Address 780 Brannan Street, San Francisco, CA, USA, 94103
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
33GF Score

Get the complete analysis for OLMA

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$11.21
Price